Education
About Us
Working with TipRanks
Follow Us
Kaneka Corporation (JP:4118)
:4118
4118 Stock Chart & Stats
¥4986.00
-¥17.00(-0.46%)
At close: 4:00 PM EST
¥4986.00
-¥17.00(-0.46%)
Day’s Range― - ―
52-Week Range¥3,146.00 - ¥5,094.00
Previous CloseN/A
Volume227.60K
Average Volume (3M)189.42K
Market Cap
¥315.31B
Enterprise Value¥474.11B
Total Cash (Recent Filing)¥44.35B
Total Debt (Recent Filing)¥212.31B
Price to Earnings (P/E)11.9
Beta0.83
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)120.21
Shares Outstanding66,000,000
10 Day Avg. Volume277,740
30 Day Avg. Volume189,416
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)0.51
Price to Sales (P/S)0.30
P/FCF Ratio-24.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,875.61Price Target Upside-2.21% Downside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Product PortfolioKaneka's diversified mix across chemicals, specialty materials and life-science products reduces exposure to any single cycle or end market. That structural diversity supports steadier revenue streams, cross-selling, and the ability to shift production toward higher-margin specialties over the next 2–6 months.
Consistent Revenue GrowthSustained revenue growth (5‑yr CAGR ~6.4%) indicates durable demand across Kaneka's end markets and successful commercialization of products. This trend underpins capacity utilization, supports reinvestment plans, and makes short-to-medium term top-line deterioration less likely absent major external shocks.
Strong Operating Cash GenerationRobust operating cash flow shows the core business converts sales into cash, enabling funding of working capital and investment without immediate reliance on external financing. Over a multi-month horizon this supports operational stability and the company’s ability to execute strategic projects despite capital intensity.
Bears Say
Negative Free Cash FlowNegative free cash flow driven by heavy capital expenditures reduces retained liquidity and raises reliance on financing or asset sales to fund growth. If high capex persists, the company may face constrained flexibility for dividends, M&A, or cushioning against cyclical downturns in the coming months.
Declining Net Profit MarginA falling net margin to ~3.1% signals pressure on the bottom line despite stable gross margins and improved operating metrics. This reduces retained earnings and makes profitability more sensitive to raw material or energy cost shocks, weakening long-term earnings resilience if margin trends continue.
Rising LeverageAn increasing debt load and a debt/equity around 0.47 raise interest and refinancing exposure, limiting financial flexibility. With negative FCF and ongoing capex, higher leverage could constrain strategic choices and increase vulnerability to rate moves or cyclical revenue dips over the next several months.
Kaneka News
4118 FAQ
What was Kaneka Corporation’s price range in the past 12 months?
Kaneka Corporation lowest stock price was ¥3146.00 and its highest was ¥5094.00 in the past 12 months.
What is Kaneka Corporation’s market cap?
Kaneka Corporation’s market cap is ¥315.31B.
When is Kaneka Corporation’s upcoming earnings report date?
Kaneka Corporation’s upcoming earnings report date is May 20, 2026 which is in 90 days.
How were Kaneka Corporation’s earnings last quarter?
Kaneka Corporation released its earnings results on Feb 10, 2026. The company reported ¥120.21 earnings per share for the quarter, beating the consensus estimate of N/A by ¥120.21.
Is Kaneka Corporation overvalued?
According to Wall Street analysts Kaneka Corporation’s price is currently Overvalued.
Does Kaneka Corporation pay dividends?
Kaneka Corporation pays a Semiannually dividend of ¥80 which represents an annual dividend yield of 3.41%. See more information on Kaneka Corporation dividends here
What is Kaneka Corporation’s EPS estimate?
Kaneka Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kaneka Corporation have?
Kaneka Corporation has 66,000,000 shares outstanding.
What happened to Kaneka Corporation’s price movement after its last earnings report?
Kaneka Corporation reported an EPS of ¥120.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.547%.
Which hedge fund is a major shareholder of Kaneka Corporation?
Currently, no hedge funds are holding shares in JP:4118
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kaneka Corporation
Kaneka Corporation manufactures and sells polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, engineering resin for injection molding, zero birefringence, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; organic EL lighting panels; and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. It also provides dairy products, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, including coenzyme, lactic-acid bacteria, and functional foodstuffs, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.
4118 Stock 12 Month Forecast
Average Price Target
¥4,875.61
▼(-2.21% Downside)
Technical Analysis
Options Prices
Currently, No data available
---